Skip to main content

Intersect ENT, Inc.

XENTDelisted May 13, 2022
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001271214

Intersect ENT, Inc. was delisted on May 13, 2022; its insiders filed their last Form 4 on May 16, 2022; 131 institutions reported holding it in 13F filings for Q1 2022, worth $828.8M in total; no superinvestor held it.

Q1 2022 vs. Q4 2021

How the institutions holding Intersect ENT, Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of XENT: Q4 2021 compared with Q1 2022
MeasureQ4 2021Of which not filed for Q1 2022Q1 2022Change
Holders1211131+11
Shares30.5M7.00K29.6M−852.4K (−2.8%)
Value$831.7M$191.0K$828.8M−$2.62M (−0.3%)

1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (23)

Institutions that held Intersect ENT, Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to XENT in Q1 2022
InstitutionSharesValue% of portfolio
Carlson Capital L P155,000$4.34M0.30%
HSBC Holdings PLC149,449$4.19M0.01%
Chicago Capital Management, LLC141,111$3.95M2.25%
Gardner Lewis Asset Management L P102,827$2.88M0.54%
Alpine Global Management, LLC100,000$2.80M0.74%
ExodusPoint Capital Management, LP43,152$1.21M0.02%
CSS LLC38,524$1.08M0.05%
Bank of Montreal32,756$918.0K0.00%
Skandinaviska Enskilda Banken AB (publ)29,511$827.0K0.00%
Tibra Equities Europe Ltd26,000$728.0K0.81%
SG Americas Securities, LLC20,724$580.0K0.01%
Vontobel Holding Ltd.20,000$560.0K0.00%
Shay Capital LLC18,231$511.0K0.18%
Boothbay Fund Management, LLC14,333$401.0K0.01%
Virtu Financial LLC14,151$396.0K0.03%
Gsa Capital Partners LLP13,013$364.0K0.05%
Vivaldi Asset Management, LLC7,166$201.0K0.02%
PenderFund Capital Management Ltd.4,900$172.0K0.04%
Amalgamated Bank5,422$152.0K0.00%
Amalgamated Financial Corp.5,422$152.0K0.00%
Covington Capital Management55$2.00K0.00%
Signaturefd, LLC40$1.00K0.00%
Northwest Investment Counselors, LLC17$00.00%

Sold out (12)

Institutions that held Intersect ENT, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of XENT in Q1 2022
InstitutionShares, Q4 2021Value, Q4 2021
Kite Lake Capital Management (UK) LLP1,320,000$36.0M
Ramius Advisors LLC268,592$7.33M
Glazer Capital, LLC144,918$3.96M
HAP Trading, LLC34,988$956.0K
Pentwater Capital Management LP25,000$683.0K
Walleye Capital LLC22,008$601.0K
First Quadrant L P20,000$546.0K
Engineers Gate Manager LP9,240$252.0K
Simplex Trading, LLC7,862$214.0K
Sagefield Capital LP6,709$183.0K
JNBA Financial Advisors500$14.0K
Delos Wealth Advisors, LLC22$1.00K

Not filed for Q1 2022 yet (1)

Institutions that held Intersect ENT, Inc. at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding XENT in Q4 2021 that haven't filed for Q1 2022
InstitutionShares, Q4 2021Value, Q4 2021
Sphinx Trading, LP7,000$191.0K